Is Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science's patent grant rate increasing or decreasing?

Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science's recent grant velocity is -95% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science

Q: Where does Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science ranks #14,400 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 21 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Yeda ranks #14,400 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 14 technology areas.

#14,400
of 49,997 US assignees by volume: Top 48%
by Innovation Score (35.9/100): 20.1
avg claims per patent: -95%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14400 · Foreign Corporation #14,400 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #14,400/49,997
PHOTO-FINISH Xage Security
CPC-FOCUS A61N · 14 areas
INNOV-THIN 35.9/100
CLAIMS-DENSE 20.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -95% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Xage Security, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Yeda’s 35.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (30%) Velocity 0.0 pts (0%) Breadth 13.2 pts (37%) Claim depth 12.0 pts (33%)

Qualcomm Incorporated · highest

85
Yeda Research &… · this assignee

36
3D Lighting… · lowest

7

What this shows Yeda's Innovation Score is 35.9/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Yeda?

Each dot is one of Yeda’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Yeda’s own 20.1 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Yeda vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Yeda's grants concentrate

Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science is a focused PatentsView assignee: 14 CPC subclasses with 33.3% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2021. By volume, Yeda sits between Xtpl S.A. and Zeavision LLC.

Xtpl

21
Xage Security

21
Xtralis

21
Xylem IP Holdings

21
Yotta Innovation

21
ZAF Energy System…

21
Zanini Auto Grup

21
Zeavision

21
Yeda Research & D… ◀

21

What this shows Yeda holds 21 patents at rank #14,398, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Yeda

By rank, the assignees closest to #14,398 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Yeda's primary technology class.

Yeda's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	28.6%
2016	4	19.0%
2017	2	9.5%
2018	4	19.0%
2019	3	14.3%
2021	1	4.8%
2025partial year	1	4.8%

Which technologies does Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

A61B - DIAGNOSIS; SURGERY; Identification 3

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 3

C07K - Peptides 2

C12Y - Enzymes 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

H10D - Inorganic Electric Semiconductor Devices 2

H10K - Organic Electric Solid-state Devices 2

A01P - Biocidal, Pest Repellant, Pest Attractant OR Plant Growth Regulatory Activity OF Chemical Compounds OR Preparations 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science's patent record in context - here's where to go next.

Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 33.3% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #14,400 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Yeda Research & Development Co Ltd. AT THE Weizmann Institute OF Science against Xtpl S.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.